Dairy and eggs

PE-backed (Paine Schwartz Partners) Dutch genetics company. Holds leading genetic positions across 6 separate protein supply chains: pigs (Hendrix Genetics Swine / Hypor + Danish Genetics, merged Jan 2025), turkeys (Hybrid Turkeys), laying hens (ISA), Atlantic salmon (Landcatch), trout (Troutlodge), shrimp (Kona Bay). 3,400+ employees, 100+ countries.

EW Group GmbH (Visbek, Lower Saxony, Germany; private, family-owned by the Wesjohann family; founded 1932 as an egg-trading business; estimated annual revenue €3B+ across all divisions) is the parent company of Hy-Line International (the world's #1 layer genetics company by chick volume) and Lohmann Tierzucht GmbH (dominant in Europe and Asia). EW Group is a closely held German family business — the Wesjohann family simultaneously controls PHW-Gruppe, Germany's largest poultry meat company (including Wiesenhof chicken), making EW Group a uniquely integrated genetics-to-meat conglomerate. Through Hy-Line and Lohmann together, EW Group controls approximately 45% of world commercial layer genetics. EW Group also owns Aviagen (broiler genetics) — a Scottish company that breeds Ross and Arbor Acres broiler lines (dominant in global broiler meat production) — meaning a single German family controls the dominant genetics for BOTH the world's egg supply (through Hy-Line + Lohmann) AND a large share of the world's chicken meat supply (through Aviagen). This dual-market position makes EW Group the most consequential private family business in global food production that most people have never heard of.

Evonik Industries AG (XETRA: EVK; Essen Germany; MDAX listed); world's largest DL-methionine producer under the MetAMINO brand. Total DL-methionine capacity exceeds 700,000 MT/year across three continental hubs: Jurong Island Singapore (~340,000 MT/year — world's largest single methionine complex, expanded +40k MT August 2024), Theodore Mobile County Alabama USA (~245,000 MT/year), and Antwerp Belgium (~120,000 MT/year). The Wesseling Germany DL-Met line closed Q1 2021 as Evonik consolidated production to the three-hub network. Evonik first commercialized DL-methionine synthesis in the 1950s under predecessor Degussa. MetAMINO is Evonik's largest single product. ~30-32% global market share. In February 2022 Evonik announced a $176.5M investment in a new methyl mercaptan (MMP intermediate feedstock) plant at the Alabama site.

Fonterra Co-operative Group Limited (Auckland, New Zealand; farmer-owned cooperative; NZX: FCG; FY2024 revenue ~NZ$22B; ~10,000 farmer-shareholders; CEO Miles Hurrell) is the world's largest dairy exporter and the dominant single player in global dairy commodity trade. Fonterra collects approximately 22 billion litres of New Zealand milk per year — roughly 90% of all milk produced in New Zealand. That milk is processed into commodity dairy ingredients: whole milk powder (WMP), skim milk powder (SMP), anhydrous milk fat (AMF), butter, and cheese. New Zealand produces approximately 3% of world milk by volume but accounts for approximately 30% of global dairy trade in milk solids — because New Zealand's pasture-based system produces surplus far beyond domestic consumption, and all of it is exported. Fonterra operates the Global Dairy Trade (GDT) auction — a Fonterra-controlled biweekly online auction that sets benchmark prices for WMP, SMP, butter, AMF, and cheddar globally. GDT prices are the benchmark against which virtually all international dairy commodity contracts are priced. Fonterra's market position means that New Zealand weather events (droughts, floods), New Zealand government milk price regulation (the Fonterra Milk Price Manual is government-supervised), and Fonterra's processing capacity constraints propagate directly into global dairy commodity prices. When Fonterra revises its forecast milk price (Farmgate Milk Price), the New Zealand dollar moves — Fonterra is so large relative to the NZ economy that the cooperative is a macro driver. Fonterra's primary processing facilities are concentrated in the Waikato (North Island, near Hamilton), Taranaki (North Island, near New Plymouth, including Whanganui), and Canterbury/South Canterbury (South Island — Studholme, Clandeboye, Edendale).

Hy-Line International (Iowa City, Iowa; wholly owned subsidiary of EW Group GmbH, Germany; founded 1936 by Henry A. Wallace — the US Secretary of Agriculture under FDR and 33rd US Vice President — as a hybrid corn and poultry breeding venture; now the world's #1 layer genetics company by commercial chick volume) produces the Hy-Line Brown (dominant in US, Latin America, and India), Hy-Line W-36 (dominant US white egg breed), and Hy-Line W-80 (ultrawhite egg, specialty market). Hy-Line maintains great-grandparent (GGP) flocks at its primary US breeding facility in Iowa City, Iowa. Hy-Line's W-36 white leghorn breed is the standard commercial layer in US cage operations and historically has been the workhorse of the US egg industry. Hy-Line was acquired by EW Group in 2000. Hy-Line supplies grandparent stock to multiplier hatcheries in 100+ countries and has technical service teams on every continent. During the 2022-2024 HPAI outbreak, Hy-Line's Iowa breeding operations were a critical chokepoint — any HPAI breach of GGP flocks at Iowa City would have required sourcing replacement GGP stock from international backup facilities, potentially adding 12-18 months to US flock repopulation timelines.

Zoetis Inc. (Parsippany NJ; NYSE: ZTS; ~$8.5B revenue FY2024; founded 2013 as Pfizer Animal Health spinoff) is the world's largest animal health company — ~20% global animal health market — and the dominant US dairy pharmaceutical supplier. Zoetis's dairy-relevant products include Lutalyse (dinoprost tromethamine — a PGF2α prostaglandin used for estrus synchronization, abortion, and pyometra treatment), CIDR (controlled internal drug release — intravaginal progesterone device for reproductive synchronization), Excede (ceftiofur crystalline free acid — third-generation cephalosporin for bovine respiratory disease), Draxxin (tulathromycin — macrolide antibiotic), and Improvac (GnRH immunocastration vaccine). Zoetis was the animal health division of Pfizer — the largest animal health company in the world hidden inside the world's largest pharmaceutical company. The 2013 IPO (raising $2.2B) revealed the scale of veterinary pharmaceutical concentration for the first time. Zoetis operates manufacturing in Kalamazoo MI, Lincoln NE, Guarulhos Brazil, Olot Spain, and Suzhou China.

Zoetis Inc. (NYSE: ZTS; ~$8.5B revenue; Parsippany NJ) is the world's largest animal health company, spun off from Pfizer in 2013. Zoetis manufactures TROVAC-NDV and conventional inactivated AI vaccines for commercial poultry, along with broad-spectrum animal health products for livestock and companion animals across 100 countries.

Boehringer Ingelheim Animal Health (Ingelheim am Rhein, Germany; private; ~€4B animal health revenue) manufactures VECTORMUNE HVT-AI recombinant poultry vaccines using herpesvirus of turkeys (HVT) as a vector. The recombinant platform simultaneously protects against Marek's disease and avian influenza. US manufacturing at Pope Valley CA and Duluth GA. Boehringer Ingelheim is the second-largest animal health company globally.

Dairy Farmers of America, Inc. (Kansas City, Missouri; farmer-owned cooperative; FY2023 revenue ~$21B; ~11,500 dairy farmer-members in 48 US states; CEO Darin Karst) is the largest US dairy cooperative and the single largest processor of US milk — collecting approximately 30% of all US raw milk production (approximately 67 billion pounds of milk per year). DFA handles milk through a network of 50+ processing plants across the US — including cheese plants (DFA is the largest US cheese producer), butter and powder facilities, fluid milk bottling plants, and specialty dairy ingredient plants. DFA's manufacturing includes American-type cheese (cheddar, colby, monterey jack), cream cheese, butter, dried milk powders, and whey proteins. DFA also operates as a milk marketing cooperative — acting as a balancer for regional milk supply, moving surplus milk between regions and processing it into storable commodities (butter, powder) when fluid milk demand is insufficient. DFA acquired the Dean Foods assets in 2020 following Dean Foods' bankruptcy (Dean Foods was the largest US fluid milk bottler; its bankruptcy reflected the long-term decline in US fluid milk consumption — down ~25% since peak). DFA's acquisition of Dean Foods gave it a dominant position in US fluid milk bottling at the same moment fluid milk demand was structurally declining — an ironic market position. DFA is the primary counterparty to US dairy farmers in most US regions.

Adisseo (Paris France; majority-owned by China National Bluestar, a subsidiary of ChemChina/Sinochem Group; formerly Rhône-Poulenc Animal Nutrition; ~€1.8B revenue) is the world's #2-3 DL-methionine producer and a major supplier of vitamins and enzymes to the animal feed industry. Adisseo manufactures Rhodimet® DL-methionine at Commentry France (primary European methionine plant since 1962) and Nanjing China (second production site). Adisseo also produces Rovimix® vitamins (Vitamin E, Vitamin A for feed) and Rovabio® NSP enzymes. The ownership of Adisseo by ChemChina (through Bluestar) — and Bluestar's ownership by Sinochem since 2018 — means that China's state chemical conglomerate controls approximately 20-25% of global DL-methionine capacity, a critical and non-substitutable poultry feed ingredient. France's historic Rhône-Poulenc agricultural chemistry (which included insecticides, herbicides, and feed additives from its Dordogne region operations) has effectively been absorbed into China's state chemical strategy through Bluestar's 2006 acquisition of Adisseo from Aventis Crop Science.

Largest producer and distributor of fresh shell eggs in the United States, producing approximately 20% of all commercially produced US eggs (~13 billion eggs/year). Revenue $4.26B in fiscal year ending May 2025 (83% growth driven by H5N1-related price surge). Total flock ~40+ million hens.

Lohmann Tierzucht GmbH (Cuxhaven, Lower Saxony, Germany; wholly owned subsidiary of EW Group GmbH; founded 1959; formerly part of BASF Animal Nutrition division before EW Group acquisition) produces the Lohmann Brown-Classic — the dominant layer breed in Europe, Southeast Asia, and the Middle East — and the Lohmann LSL-Classic (white egg, dominant in Germany, Netherlands, and Scandinavia). The Lohmann Brown-Classic produces 300-330 eggs per year under commercial conditions, with excellent livability and adaptive performance in cage-free environments — making it the preferred breed as EU cage-free transition mandates take effect. Lohmann maintains GGP flocks in Cuxhaven (Germany) and internationally. Lohmann is the market leader in Germany (naturally — the home of EW Group) and holds strong positions across Europe, Turkey, India, and Southeast Asia. Lohmann's Cuxhaven headquarters and breeding facilities represent a second critical node in EW Group's GGP infrastructure, alongside Hy-Line's Iowa City facility.

Cargill, Incorporated (Wayzata MN; private; ~$177B revenue FY2023; founded 1865; largest private company in the US by revenue) is the world's third-largest soybean crusher by capacity and the largest private commodity trading firm globally. Cargill operates soybean processing facilities in the US (Eddyville IA, Iowa Falls IA, Memphis TN, Wichita KS, Sidney OH) and Brazil (multiple Mato Grosso do Sul and Parana state locations). Cargill's animal nutrition division (Cargill Premix and Nutrition) directly sells soybean meal-based swine feed supplements and complete swine feed rations to US hog producers — vertically integrating crush to feed formulation. Cargill is both a major soybean meal producer (from its crush operations) and a major swine feed seller (through its nutrition business), making it uniquely positioned across the soybean-to-pork value chain. Cargill is family-controlled (Whitney MacMillan family) and does not report detailed financial segments publicly. US soybean crush: Cargill holds an estimated 15-20% of US crush capacity.

Ceva Santé Animale (Libourne, France; private; ~€1.7B revenue) is the 5th largest animal health company globally and a major poultry vaccine manufacturer. Ceva produces MAFIVAC AI vaccines, VECTORMUNE ND+AI recombinant vaccines, and other poultry biologicals. Ceva has significant manufacturing in France (Libourne + Pau), Spain, and the US. In 2022-2024, Ceva supplied emergency AI vaccines to France's commercial duck industry during HPAI H5N1 outbreaks.

Elanco Animal Health Inc. (Greenfield IN; NYSE: ELAN; ~$4.4B revenue FY2024; spun off from Eli Lilly in 2018 IPO; acquired Bayer Animal Health 2020 for $7.6B) is the #2 or #3 animal health company globally behind Zoetis and closely competing with Boehringer Ingelheim. The Bayer Animal Health acquisition added major dairy-relevant products: Baytril (enrofloxacin — fluoroquinolone antibiotic), Advocate/Advantage (parasiticides), and Seresto. Elanco's legacy Lilly Animal Health products include Posilac (recombinant bovine somatotropin — rBST — the controversial bovine growth hormone) and mastitis treatment products. Elanco is a major supplier of intramammary mastitis treatments (Pirsue/pirlimycin, ToDAY/cloxacillin dry cow tubes) for the US dairy industry. The 2020 Bayer Animal Health acquisition made Elanco a genuine global challenger to Zoetis but also burdened Elanco with significant debt ($5.4B), resulting in ongoing cost-cutting and divestitures.

Merck Animal Health (Madison NJ; division of Merck & Co.; ~$5.5B revenue) manufactures AviPro brand avian influenza and Newcastle disease vaccines for commercial poultry. Products sold as MSD Animal Health outside North America. Merck Animal Health is the third-largest animal health company globally. De Soto KS biologics manufacturing site.

Novus International (Chesterfield / St. Charles MO USA; owned 80% Mitsui & Co. Japan + 20% Nippon Soda Japan); global animal nutrition company producing ALIMET (HMTBa — 2-hydroxy-4-(methylthio)butanoic acid), a liquid methionine hydroxy analog that is approved as bioequivalent to DL-methionine in poultry and swine diets. ALIMET plant at Chocolate Bayou TX near Alvin Brazoria County (~284,000 MT/year nameplate capacity; first shipment 1984). Also produces MFP (Methionine Feed Grade Powder) and gut health products. ~10-15% global methionine market share. Note: ALIMET is an analog (not identical to dry DL-methionine) — approved by FDA and EU for equivalent nutritional use in poultry. US-based production is Japanese-owned, not American-owned. Revenue ~$650M/year.

World's largest private animal nutrition company; 10.5% of global animal feed protein market (2024). Produces compound feed for poultry, swine, aquaculture, cattle, and dairy across 70+ countries. Vertically integrated from grain trading to branded nutrition products. Controls significant soybean crushing and corn processing capacity globally.